Noramco
Noramco
Noramco
  • About Us
    • About Noramco
    • Our People
    • Leadership
    • Excellence in Compliance
    • Minimizing Risk
  • Products & Solutions
    • Active Pharmaceutical Ingredients
      • Active Pharmaceutical Ingredients
      • Nal Family of Antagonists
      • ADHD / Stimulants
      • Full Product List
    • Noramco Solutions
      • Noramco Solutions
      • Clinical Supply
      • Controlled Substance Building Blocks and Intermediates
    • Platform Technologies
      • Platform Technologies
      • Platform Technology: Custom Synthesis
    • Reference Standards
      • Reference Standards
      • Reference Standards: Custom Synthesis
    • Reference Standards Store
  • Careers
  • News & Events
    • News & Events
    • Press Releases
  • Contact

Sort by

  • Default sorting
  • Sort by popularity
  • Sort by newness
  • Sort by price: low to high
  • Sort by price: high to low

View

  • 9 items
  • 15 items
  • 30 items

Showing 1–9 of 17 results

  • 183_Oxymorphone-Aldol-Dimer
    Quick ViewSelect options

    Oxycodone Aldol Dimer (CII)

    $4,750.00 – $19,000.00
    <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-2171-**</p>
    Quick ViewSelect options
  • 152_10-Ketooxycodone-Base
    Quick ViewSelect options

    10-Ketooxycodone Base (CII)

    $1,438.00 – $5,752.00
    <p class="p1"><span style="color: #000000;"><strong>CAS#</strong></span> 96445-11-3</p> <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-2126-**</p>
    Quick ViewSelect options
  • 151_10-Hydroxyoxycodone-Base
    Quick ViewSelect options

    10-Hydroxyoxycodone Base (CII)

    $1,438.00 – $5,752.00
    <p class="p1"><span style="color: #000000;"><strong>OTHER NAMES:</strong></span> USP Impurity</p> <p class="p1"><span style="color: #000000;"><strong>CAS#</strong></span> 96453-12-2</p> <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-2005-**</p>
    Quick ViewSelect options
  • 63_Codeinone-Base
    Quick ViewSelect options

    Codeinone Base (CII)

    $1,150.00 – $4,600.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 467-13-0 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0998-**
    Quick ViewSelect options
  • 165_Oxycodone-N-Oxide
    Quick ViewSelect options

    Oxycodone N-Oxide (CII)

    $863.00 – $3,452.00
    <p class="p1"><span style="color: #000000;"><strong>OTHER NAMES:</strong></span> USP Compound B</p> <p class="p1"><span style="color: #000000;"><strong>CAS#</strong></span> 71539-52-1</p> <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-0908-**</p>
    Quick ViewSelect options
  • 156_7-Methyloxycodone-Base
    Quick ViewSelect options

    7-Methyloxycodone Base (CII)

    $863.00 – $3,452.00
    <p class="p1"><span style="color: #000000;"><strong>CAS#</strong></span> 2859-09-8</p> <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-1032-**</p>
    Quick ViewSelect options
  • 153_14-Hydroxycodeinone-Base-
    Quick ViewSelect options

    14-Hydroxycodeinone Base (CII)

    $719.00 – $2,876.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 508-54-3 <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-0906-**</p>
    Quick ViewSelect options
  • 163_Oxycodone-Ethyl-Enolate
    Quick ViewSelect options

    Oxycodone Ethyl Enolate (CII)

    $575.00 – $2,300.00
    <p class="p1"><span style="color: #000000;"><strong>CAS#</strong></span> 100740-55-4</p> <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-0919-**</p>
    Quick ViewSelect options
  • 159_Noroxycodone-Hydrochloride
    Quick ViewSelect options

    Noroxycodone Hydrochloride (CII)

    $575.00 – $2,300.00
    <span style="color: #000000;"><strong>OTHER NAMES:</strong></span> EP Impurity C <p class="p1"><span style="color: #000000;"><strong>CAS#</strong></span> 52446-25-0</p> <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-1057-**</p>
    Quick ViewSelect options
  • 1
  • 2

Recent Articles

  • The Security of Onshore Manufacturing
  • Noramco CEO Lee Karras discusses $25 million Halo investment with PharmTech
  • Diversifying the Supply of Raw Materials
  • Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider
  • Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
Copyright 2025 Noramco. All Rights Reserved. Contact | Legal Notice | Privacy Policy | Terms & Conditions | Benefits Transparency Mandate